Last updated: 11/03/2018 16:37:38
Prevalence-based health and economic model of the bivalent versus the quadrivalent human papillomavirus (HPV) vaccine
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Finalized
Finalized
Trial overview
Official title: Additional Health and Economic Impact of the bivalent versus the quadrivalent HPV vaccine in Taiwan: results of a prevalence-based model
Trial description: This study compares the health and economic impact of the bivalent HPV vaccine (HPV-1) and the quadrivalent HPV vaccine (HPV-2).
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Annual number of lesions prevented by each vaccine
Timeframe: Over a one-year period
Lesion related total cost averted by each vaccine
Timeframe: Over a one-year period
Additional costs averted by HPV-1 vaccine compared to HPV-2 vaccine
Timeframe: Over a one-year period
Secondary outcomes:
Not applicable
Interventions:
Other: Prevalence-based model
Enrollment:
1
Observational study model:
Other
Primary completion date:
Not applicable
Time perspective:
Other
Clinical publications:
ADDITIONAL HEALTH AND ECONOMIC IMPACT OF THE BIVALENT VERSUS THE QUADRIVALENT HPV VACCINE IN TAIWAN: RESULTS OF A PREVALENCE-BASED MODEL, Ho. T.H., van Enckevort, P.J. & Demarteau, N. Poster presented at: ISPOR, 4th Asia-Pacific Conference, 5-7 September 2010, Phuket, Thailand.
Medical condition
Human Papillomavirus Infection
Product
SB580299
Collaborators
Not applicable
Study date(s)
February 2010 to February 2010
Type
Observational
Phase
Not applicable
Participation criteria
Sex
Female
Age
Not applicable+ years
Accepts healthy volunteers
Yes
- Female subjects vaccinated with either HPV-1 or HPV-2 vaccines in Taiwan (hypothetical group).
- Not applicable.
Inclusion and exclusion criteria
Inclusion criteria:
- Female subjects vaccinated with either HPV-1 or HPV-2 vaccines in Taiwan (hypothetical group).
Exclusion criteria:
- Not applicable.
Trial location(s)
No location data available.
Study documents
Scientific result summary
Available language(s): English
If you wish to request for full study report, please contact - [email protected]
Results overview
Refer to study documents
Recruitment status
Finalized
Actual primary completion date
Not applicable
Actual study completion date
2010-23-02
Plain language summaries
Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.
Additional information about the trial
Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website